DISCLAIMER
The information on this website has not been independently verified as to correctness or completeness and this document does therefore not purport to be correct or complete. This website does not constitute an audit, a due diligence or any similar review and should not be construed as such nor does it serve as a respective substitute. This website should therefore not form the basis of any decision be relied on for any purpose and should not in any way serve as a substitute for other enquiries and procedures that would (or should) otherwise be undertaken.
To the extent permitted by law no representation or warranty, expressed or implied, is or will be made and no responsibility or liability is or will be accepted by the Company or by any of their respective directors, officers, servants, advisers, agents or affiliates as to or in relation to the accuracy, sufficiency or completeness of this document or the information forming the basis of the document or for any errors, omissions or misstatements relating thereto. In particular, without limitation, no representation or warranty, expressed or implied, is or will be made as to the achievement or reasonableness of, and no reliance should be placed on, any projection, targets, estimates, forecasts and nothing in this document should be relied on as a promise or representation as to the future.
The Fund Documents and this website of are for information purposes only. Nothing contained therein constitutes or shall be deemed to constitute a financial, legal, tax or other advice of any kind and no information on the website shall constitute or deem to constitute a solicitation or an offer to purchase, or invest in, any financial products which are referred to on this website. This website is specifically not aimed at parties who are residents of any country where the funds referred to herein are not registered or approved for marketing and/or sale or dissemination of information on the funds or services is not permitted. 4 BIO cannot make any representation or warranty of any nature, expressly or implicitly, about the fund documents. You should not rely solely on the information contained on the Website.
SFDR DISCLOSURE
Mandatory disclosures under Regulation of the European Parliament and of the Council on sustainable-related disclosures in the financial services sector (EU) 2019/2088 (“SFDR”).
4BIO Partners LLP (“4BIO Capital”) considers sustainability risks as part of its investment decision-making process. Sustainability risks are environmental, social or governance events or conditions, the occurrence of which could have an actual or potential material adverse effect on the value of the investment. 4BIO Capital remains free in its decision to refrain from investing or to invest despite sustainability risks in which case 4BIO Capital can also apply measures to reduce or mitigate any sustainability risks. At all times, 4BIO Capital will apply the principle of proportionality taking due account of the strategic relevance of an investment as well as its transactional context.
4BIO Capital pursues a venture capital strategy and invests in companies within the advanced therapies sector. Given that there are rarely adverse impacts on sustainability factors within advanced therapies 4BIO Capital does not formally consider adverse impacts of investment decisions on sustainability, however, should there occur adverse impacts during the investment process, 4BIO Capital will evaluate those adverse impacts and in case of a negative outcome will refrain from an investment.
4BIO Capital has not identified any adverse sustainability impacts related to its investments to date.
Given that the Sustainable Finance Disclosure Regulation (EU 2019/2088) (“SFDR“) and the accompanying Regulatory Technical Standards (“RTS“) are new legislative acts, there is very little or no practical experience or practice with regard to applying their respective provisions. Therefore, substantial legal uncertainties would remain when applying those provisions to the strategies pursued by 4BIO Capital. If and to the extent that these uncertainties will be resolved and a practicable market and administrative practice will evolve in this regard, 4BIO Capital will reevaluate following them in due course.
At 4BIO Capital we stand by the principles of responsible investment in our internal and external processes and policies to ensure alignment with our fundamental commitment to pursuing long-term financial returns for our clients. We are currently not signatories of UN Principles for Responsible Investment.
Kanto Local Finance Bureau regulatory compliance: